1. Search Result
Search Result
Results for "

inositol phosphate

" in MedChemExpress (MCE) Product Catalog:

177

Inhibitors & Agonists

34

Biochemical Assay Reagents

7

Peptides

1

MCE Kits

1

Inhibitory Antibodies

32

Natural
Products

11

Recombinant Proteins

9

Isotope-Labeled Compounds

11

Antibodies

8

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B1411
    i-Inositol
    5 Publications Verification

    myo-inositol; meso-inositol

    Endogenous Metabolite Others
    i-Inositol (myo-Inositol) is a compound of sugar alcohols. i-Inositol is involved in a series of biological processes such as insulin signal transduction and cytoskeletal transduction. i-Inositol mainly exists in glial cells and plays an osmotic role .
    i-Inositol
  • HY-B1411R

    myo-inositol (Standard); meso-inositol (Standard)

    Reference Standards Endogenous Metabolite Others
    i-Inositol (Standard) is the analytical standard of i-Inositol. This product is intended for research and analytical applications. i-Inositol (myo-Inositol) is a compound of sugar alcohols. i-Inositol is involved in a series of biological processes such as insulin signal transduction and cytoskeletal transduction. i-Inositol mainly exists in glial cells and plays an osmotic role .
    i-Inositol (Standard)
  • HY-W016509

    Drug Derivative Neurological Disease
    epi-Inositol, a inositol analog, is an antidepressant agent. epi-Inositol shows regulatory effects on expression of the most highly regulated gene in the inositol biosynthetic pathway. epi-Inositol shows antiepileptic effect .
    epi-Inositol
  • HY-122365R

    inositol niacinate (Standard); Hexanicit (Standard)

    Drug Derivative Reference Standards Cardiovascular Disease
    Inositol nicotinate (Standard) is the analytical standard of Inositol nicotinate. This product is intended for research and analytical applications. Inositol nicotinate, with vasodilatory effect, is used in the study of Peripheral arterial disease (PAD) .
    Inositol nicotinate (Standard)
  • HY-121962

    Endogenous Metabolite Metabolic Disease
    neo-Inositol, a stereoisomer of inositol, has been isolated from calf brain .
    neo-Inositol
  • HY-B1411S1

    myo-inositol-d1; meso-inositol-d1

    Isotope-Labeled Compounds Endogenous Metabolite Others
    i-Inositol-d is the deuterium labeled i-Inositol .
    i-Inositol-d1
  • HY-B1411S

    myo-inositol-d6; meso-inositol-d6

    Endogenous Metabolite Others
    i-Inositol-d6 is the deuterium labeled i-Inositol. i-Inositol is a chemical compound, associated lipids are found in many foods, in particular fruit, especially cantaloupe and oranges.
    i-Inositol-d6
  • HY-172573

    2,3,5,6-IP4 tetrasodium; Ins(2,3,5,6)-P4 tetrasodium

    Calcium Channel Others
    D-myo-Inositol-2,3,5,6-tetraphosphate (2,3,5,6-IP4) tetrasodium is a inositol phosphate. D-myo-Inositol-2,3,5,6-tetraphosphate tetrasodium can be used for the study of calcium channels .
    D-myo-Inositol-2,3,5,6-tetraphosphate tetrasodium
  • HY-172570

    Ins(1,2,3,5,6)-P5 tetrasodium; 1,2,3,5,6-IP5 tetrasodium

    Calcium Channel Others
    D-myo-inositol-1,2,3,5-tetraphosphate (Ins(1,2,3,5,6)-P5) tetrasodium is one of the Inositol phosphate isomers and can act as a soluble second messenger to participate in cellular calcium signaling .
    D-myo-Inositol-1,2,3,5-tetraphosphate tetrasodium
  • HY-W016509R

    Endogenous Metabolite Drug Derivative Neurological Disease
    epi-Inositol (Standard) is the analytical standard of epi-Inositol (HY-W016509). This product is intended for research and analytical applications. epi-Inositol, a inositol analog, is an antidepressant agent. epi-Inositol shows regulatory effects on expression of the most highly regulated gene in the inositol biosynthetic pathway. epi-Inositol shows antiepileptic effect .
    epi-Inositol (Standard)
  • HY-125150

    11-Deoxy-16-fluoro PGF2α

    Prostaglandin Receptor Endogenous Metabolite Endocrinology
    AL-3138 (11-Deoxy-16-fluoro PGF2α) is a prostaglandin F2 alpha (PGF2alpha) analogue that antagonises FP prostaglandin receptor-mediated inositol phosphate production .
    AL-3138
  • HY-P3061

    Bradykinin Receptor Cardiovascular Disease Endocrinology
    [Hyp3]-Bradykinin, naturally occurring peptide hormone, is a bradykinin receptor agonist. [Hyp3]-Bradykinin interacts with B2-bradykinin receptors and stimulates inositol phosphate production in cultured human fibroblasts .
    [Hyp3]-Bradykinin
  • HY-122365

    inositol niacinate; Hexanicit

    Drug Derivative Cardiovascular Disease
    Inositol nicotinate (Hexanicit) has vasodilating effects and can be used in research on peripheral arterial disease, showing efficacy when taken orally. Inositol nicotinate does not significantly improve triglyceride levels in mice induced by biphenyl esters .
    Inositol nicotinate
  • HY-P10270

    PDGFR Mitosis Others
    PDGFR Y1021 peptide (phosphorylation) is the phosphorylated fragment of platelet-derived growth factor receptor (PDGFR). PDGFR Y1021 peptide (phosphorylation) supports association of PLCγ to PDGFR through PLCγSH2 domains, and thus promotes the production of inositol phosphates and mitogenic response .
    PDGFR Y1021 peptide (phosphorylation)
  • HY-175476

    IPK Superfamily Cancer
    UNC7437 is a inositol phosphate multikinase (IPMK) inhibitor, with an IC50 value of 26.2 nM. UNC7437 exhibits anti-proliferative activity against glioblastoma cells. UNC7437 decreases the accumulation of InsP4, InsP5, and InsP6 in cells. UNC7437 can be used for the study of TEN-negative glioblastoma models .
    UNC7437
  • HY-P4987

    Protease Activated Receptor (PAR) Cardiovascular Disease
    TRAP-7 is a thrombin receptor (PAR) activating peptide. TRAP-7 stimulates total inositol phosphate (IP) accumulation and phosphorylation of a specific endogenous substrate for activated PKC. TRAP-7 can be used in cardiovascular disease research .
    TRAP-7
  • HY-W010041

    α-synuclein Amyloid-β Neurological Disease
    Scyllo-Inositol is an inhibitor that targets the aggregation of misfolded proteins (such as α-synuclein and Amyloid-β), is orally effective, and can cross the blood-brain barrier. Scyllo-Inositol can selectively bind to and stabilize non-toxic oligomers, preventing them from converting into toxic fibers, exerting protein homeostasis regulation and neuroprotective activity. Scyllo-Inositol binds to the hydrophobic region of pathogenic proteins, inhibits protein aggregation, and promotes lysosome- and proteasome-mediated degradation pathways, thereby reducing neurotoxicity. Scyllo-Inositol can be used in the study of neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and Huntington's disease .
    Scyllo-Inositol
  • HY-N3021

    Endogenous Metabolite NF-κB TNF Receptor FOXO Microtubule/Tubulin Metabolic Disease
    D-chiro-Inositol is a stereoisomer of inositol that exhibits activities such as improving glucose metabolism, anti-tumor effects, anti-inflammatory properties, and antioxidant activity. D-chiro-Inositol effectively alleviates cholestasis by enhancing bile acid secretion and reducing oxidative stress. D-chiro-Inositol improves insulin resistance, lowers hyperglycemia and circulating insulin levels, reduces serum androgen levels, and ameliorates some metabolic abnormalities associated with X syndrome by mimicking the action of insulin. Additionally, D-chiro-Inositol can induce a reduction in pro-inflammatory factors (such as Nf-κB) and cytokines (such as TNF-α), thereby exerting anti-inflammatory effects. D-chiro-Inositol may be used in the study of liver cirrhosis, breast cancer, type 2 diabetes, and polycystic ovary syndrome .
    D-chiro-Inositol
  • HY-167815

    Biochemical Assay Reagents
    Myo-Inositol hexasulfate hexapotassium is a sulfated derivative of inositol that has the activity of mimicking highly sulfated polysaccharides such as heparin, affecting many cell signaling pathways.
    myo-Inositol hexasulfate hexapotassium
  • HY-W788583

    Calcium Channel Metabolic Disease
    Inositol 1,3-bisphosphate sodium is one of the many inositol phosphate (InsP) isomers that could act as small, soluble second messengers in the transmission of cellular signals .
    Inositol 1,3-bisphosphate sodium
  • HY-141510

    ITPP hexasodium

    HIF/HIF Prolyl-Hydroxylase Cardiovascular Disease Cancer
    myo-Inositol trispyrophosphate (ITPP) hexasodium is a salt form of inositol triphosphate (ITPP). myo-Inositol trispyrophosphate (ITPP) hexasodium is a membrane-permeant hemoglobin allosteric regulator. myo-Inositol trispyrophosphate (ITPP) hexasodium enhances the oxygen release capacity of red blood cells by reducing the affinity of hemoglobin to oxygen. myo-Inositol trispyrophosphate (ITPP) hexasodium can be used in the study of cardiovascular disease and cancer .
    myo-Inositol trispyrophosphate hexasodium
  • HY-W707693

    Isotope-Labeled Compounds Amyloid-β α-synuclein Neurological Disease
    Scyllo-Inositol-d6 is the deuterium labeled Scyllo-Inositol (HY-W010041). Scyllo-Inositol is an inhibitor that targets the aggregation of misfolded proteins (such as α-synuclein and Amyloid-β), is orally effective, and can cross the blood-brain barrier. Scyllo-Inositol can selectively bind to and stabilize non-toxic oligomers, preventing them from converting into toxic fibers, exerting protein homeostasis regulation and neuroprotective activity. Scyllo-Inositol binds to the hydrophobic region of pathogenic proteins, inhibits protein aggregation, and promotes lysosome- and proteasome-mediated degradation pathways, thereby reducing neurotoxicity. Scyllo-Inositol can be used in the study of neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and Huntington's disease .
    Scyllo-Inositol-d6
  • HY-N2581R

    myo-inositol, hexakis(dihydrogen phosphate) sodium salt (Standard); inositol hexaphosphate sodium salt (Standard)

    Reference Standards Endogenous Metabolite Others
    Phytic acid (sodium salt) (Standard) is the analytical standard of Phytic acid (sodium salt). This product is intended for research and analytical applications. Phytic acid sodium salt (myo-Inositol; hexakis dihydrogen phosphate; Inositol hexaphosphat) is often present in legume seeds with antinutritional effects. Phytic acid sodium salt is a [PO4]3- storage depot and precursor for other inositol phosphates and pyrophosphates. phytic acid is hydrolyzed by phytases in a stepwise manner in the plant .
    Phytic acid sodium salt (Standard)
  • HY-W145684

    myo-inositol-TMS

    Biochemical Assay Reagents Others
    Trimethylsilyl-meso-inositol is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    Trimethylsilyl-meso-inositol
  • HY-N2581
    Phytic acid sodium salt
    1 Publications Verification

    myo-inositol, hexakis(dihydrogen phosphate) sodium salt; inositol hexaphosphate sodium salt

    Endogenous Metabolite Amyloid-β Autophagy Cardiovascular Disease Neurological Disease Metabolic Disease Cancer
    Phytic acid sodium salt (myo-Inositol; hexakis dihydrogen phosphate; Inositol hexaphosphate) is an orally active compound derived from the seeds of legumes. Phytic acid sodium salt is a [PO4] 3- storage depot and precursor for other inositol phosphates and pyrophosphates. phytic acid is hydrolyzed by phytases in a stepwise manner in the plant. Phytic acid sodium salt attenuates oligomers and upregulates autophagy protein. Phytic acid sodium salt can be used in cardiovascular disease, metabolic disease, nervous system disease and cancer research .
    Phytic acid sodium salt
  • HY-N3021R

    Endogenous Metabolite NF-κB TNF Receptor FOXO Microtubule/Tubulin Metabolic Disease
    D-chiro-Inositol is a stereoisomer of inositol that exhibits activities such as improving glucose metabolism, anti-tumor effects, anti-inflammatory properties, and antioxidant activity. D-chiro-Inositol effectively alleviates cholestasis by enhancing bile acid secretion and reducing oxidative stress. D-chiro-Inositol improves insulin resistance, lowers hyperglycemia and circulating insulin levels, reduces serum androgen levels, and ameliorates some metabolic abnormalities associated with X syndrome by mimicking the action of insulin. Additionally, D-chiro-Inositol can induce a reduction in pro-inflammatory factors (such as Nf-κB) and cytokines (such as TNF-α), thereby exerting anti-inflammatory effects. D-chiro-Inositol may be used in the study of liver cirrhosis, breast cancer, type 2 diabetes, and polycystic ovary syndrome .
    D-chiro-Inositol (Standard)
  • HY-W010041R

    α-synuclein Amyloid-β Neurological Disease
    Scyllo-Inositol is an inhibitor that targets the aggregation of misfolded proteins (such as α-synuclein and Amyloid-β), is orally effective, and can cross the blood-brain barrier. Scyllo-Inositol can selectively bind to and stabilize non-toxic oligomers, preventing them from converting into toxic fibers, exerting protein homeostasis regulation and neuroprotective activity. Scyllo-Inositol binds to the hydrophobic region of pathogenic proteins, inhibits protein aggregation, and promotes lysosome- and proteasome-mediated degradation pathways, thereby reducing neurotoxicity. Scyllo-Inositol can be used in the study of neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and Huntington's disease .
    Scyllo-Inositol (Standard)
  • HY-167287

    Biochemical Assay Reagents Others
    myo-Inositol,tetraphosphate,pentaammonium salt is a biochemical reagent.
    myo-Inositol,tetraphosphate,pentaammonium salt
  • HY-W145699

    Biochemical Assay Reagents Endogenous Metabolite Others
    D-myo-Inositol 4-mono-phosphate, also known as IMP, is a phosphorylated form of inositol that is commonly found in various metabolic pathways, especially in the biosynthesis of phospholipids and cell signaling molecules. D-myo-Inositol 4-mono-phosphate has unique chemical properties that make it an important intermediate in the production of second messengers, such as inositol triphosphate (IP3) and diacylglycerol (DAG), which signal in cells plays a key role in. D-myo-Inositol 4-mono-phosphate is also used in dietary supplements and pharmaceuticals because of its potential health benefits, including improved insulin sensitivity and cognitive function.
    D-myo-Inositol 4-monophosphate
  • HY-W127726

    Biochemical Assay Reagents Others
    allo-Inositol is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    Allo-inositol
  • HY-141510A

    ITPP hexa-triethylamine

    Biochemical Assay Reagents HIF/HIF Prolyl-Hydroxylase Cardiovascular Disease Cancer
    myo-Inositol trispyrophosphate (ITPP) hexa-triethylamine is a salt form of inositol triphosphate (ITPP). myo-Inositol trispyrophosphate hexa-triethylamine is a membrane-permeant hemoglobin allosteric regulator. myo-Inositol trispyrophosphate hexa-triethylamine enhances the oxygen release capacity of red blood cells by reducing the affinity of hemoglobin to oxygen. myo-Inositol trispyrophosphate hexa-triethylamine can be used in the study of cardiovascular disease and cancer .
    myo-Inositol trispyrophosphate hexa-triethylamine
  • HY-114667

    EGFR Others
    Lavendustin C6 is a specific inhibitor of tyrosine kinase. Lavendustin C6 inhibits epidermal growth factor (EGF) receptor tyrosine kinase with an EC50 value of 0.05 μg/mL. Lavendustin C6 inhibits platelet-derived growth factor (PDGF)-induced inositol phosphate formation .
    Lavendustin C6
  • HY-175477

    DAPK DYRK PDGFR IPK Superfamily Cancer
    UNC9750 is an inositol phosphate multikinase (IPMK) inhibitor with IC50 values ​​of 31.6 and 374 nM for IPMK and IP6K2, respectively.. UNC9750 inhibits cellular accumulation of InsP5, the direct product of IPMK kinase activity, while having no effect on either InsP6 or InsP7 levels. UNC9750 has ≥ 75% inhibition of four kinases (DAPK1, DYRK1B, PDGFR, and KDR). UNC9750 can be used for the study of glioblastoma .
    UNC9750
  • HY-125641A

    5-HT Receptor Neurological Disease
    AL-34662 (formate) is a 5-HT2 receptor agonist (IC50: 0.8-1.5 nM). AL-34662 (formate) stimulates inositol phosphate turnover and Ca 2+ release in human ciliary muscle cells (h-CM) (E50: 289 nM) and human trabecular meshwork cells (h-TM) (E50: 254 nM). AL-34662 (formate) can be used in studies to lower intraocular pressure (IOP) .
    AL-34662 formate
  • HY-W403046

    Biochemical Assay Reagents Others
    D-myo-Inositol-4-phosphate (ammonium) is a biochemical reagent.
    D-myo-Inositol-4-phosphate ammonium
  • HY-175384

    Ins(3)P1 sodium salt; 3-IP1 sodium

    Endogenous Metabolite Others
    D-myo-Inositol-3-phosphate (sodium) is one of the members in inositol phosphate family of second messengers that play an important role in transmitting cellular signals. D-myo-Inositol-3-phosphate (sodium) can be formed by the dephosphorylation of polyphosphate inositols .
    D-myo-Inositol-3-phosphate sodium
  • HY-175385

    Ins(1)P1 sodium; 1-IP1 sodium salt

    Endogenous Metabolite Others
    D-myo-Inositol-1-phosphate (sodium salt) is one of the members in inositol phosphate family of second messengers that play an important role in transmitting cellular signals. D-myo-Inositol-1-phosphate (sodium salt) can be formed by the dephosphorylation of polyphosphate inositols .
    D-myo-Inositol-1-phosphate sodium salt
  • HY-N2421
    Sequoyitol
    1 Publications Verification

    5-O-Methyl-myo-inositol

    Others Metabolic Disease
    Sequoyitol (5-O-Methyl-myo-inositol) is isolated from plants. Sequoyitol (5-O-Methyl-myo-inositol) decreases blood glucose, improves glucose intolerance, and is used to treat diabetes .
    Sequoyitol
  • HY-137325

    Guanylate Cyclase Others
    2-Chloro-ATP is a soluble guanylate cyclase inhibitor that increases intracellular calcium concentration at low concentrations through a mechanism independent of inositol phosphate production .
    2-Chloro-ATP
  • HY-W726084

    Drug Derivative Metabolic Disease
    1,2:5,6-Di-O-isopropylidene-L-chiro-inositol is a derivative of inositol .
    1,2:5,6-Di-O-isopropylidene-L-chiro-inositol
  • HY-W794363

    Calcium Channel Metabolic Disease
    D-myo-Inositol-1,4,5,6-tetraphosphate sodium is one of several different inositol oligophosphate isomers implicated in signal transduction .
    D-myo-Inositol-1,4,5,6-tetraphosphate sodium
  • HY-W794205

    Biochemical Assay Reagents Others
    D-myo-Inositol 4-monophosphate (biscyclohexylammonium) is a biochemical reagent.
    D-myo-Inositol 4-monophosphate biscyclohexylammonium
  • HY-12613

    NSC 45109

    Drug Derivative Fungal Others
    2-C-methylene-myo-inositol oxide (NSC 45109), an inositol derivative, induces pseudohyphae formation in Saccharomyces spp .
    2-C-methylene-myo-inositol oxide
  • HY-W793477

    Biochemical Assay Reagents
    D-myo-Inositol 1-monophosphate (dipotassium) is a biochemical reagent .
    D-myo-Inositol 1-monophosphate dipotassium
  • HY-175118

    Scyllo-IP6 sodium

    Drug Isomer Others
    Scyllo-Inositol hexakisphosphate (Scyllo-IP6) sodium is a orthophosphate monoester found in lake sediments .
    Scyllo-Inositol hexakisphosphate sodium
  • HY-133690

    Calcium Channel Metabolic Disease
    D-myo-Inositol-1,3,4,5-tetraphosphate sodium is formed by the phosphorylation of Ins(1,4,5)P3 by inositol 1,4,5-triphosphate 3-kinase.
    D-myo-Inositol-1,3,4,5-tetraphosphate sodium
  • HY-W790474

    Biochemical Assay Reagents Others
    D-myo-Inositol 1,3,4-tris-phosphate is a biochemical assay reagent.
    D-myo-Inositol 1,3,4-tris-phosphate
  • HY-103642A

    inositol 1,4,5-trisphosphate trisodium; Ins(1,4,5)-P3 trisodium

    Calcium Channel Metabolic Disease
    D-myo-Inositol-1,4,5-triphosphate sodium salt is the trisodium salt of D-myo-Inositol 1,4,5-trisphosphate (1,4,5-IP3), which is a second messenger that stimulates the discharge of calcium from the endoplasmic reticulum.
    D-myo-Inositol-1,4,5-triphosphate trisodium
  • HY-103642

    inositol 1,4,5-trisphosphate hexapotassium salt; Ins(1,4,5)-P3 hexapotassium salt

    Calcium Channel Metabolic Disease
    D-myo-Inositol 1,4,5-trisphosphate hexapotassium salt is the hexapotassium salt of D-myo-Inositol 1,4,5-trisphosphate (1,4,5-IP3), which is a second messenger that stimulates the discharge of calcium from the endoplasmic reticulum.
    D-myo-Inositol 1,4,5-trisphosphate hexapotassium salt
  • HY-137608A

    UDP-β-S trisodium

    P2Y Receptor DNA/RNA Synthesis Cardiovascular Disease
    Uridine 5'-O-thiodiphosphate (trisodium) (UDP-β-S (trisodium)) is a purinergic P2Y6 receptor agonist. Uridine 5'-O-thiodiphosphate (trisodium) selectively induces accumulation of inositol phosphates in 1321N1 cells expressing P2Y6 receptors (EC50 = 28 nM). Uridine 5'-O-thiodiphosphate (trisodium) induces DNA synthesis in rat aortic smooth muscle cells .
    Uridine 5'-O-thiodiphosphate trisodium

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: